American Journal of Perinatology · 2022 · 10 citations · 37 references
Public HealthMaternal HealthObstetricsHigh-risk PregnancyReproductive HealthWomen's HealthBirth Outcomes EpidemiologyFetal OutcomesMaternal ComplicationsPregnancyPreterm Birth EpidemiologyRisk Factors For Preterm BirthCohort Study InvestigationMaternal Electronic Health RecordsMaternal Infectious DiseasesMaternal Outcome AssessmentPreterm Birth IncidencePreterm Birth PrevalenceSars-cov-2 InfectionSevere Acute Respiratory Syndrome
Objective This study was aimed to evaluate how the novel coronavirus disease 2019 (COVID-19) pandemic may have negatively impacted birth outcomes in patients who tested negative for the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus. Study Design We conducted a retrospective cohort study using electronic health records of pregnant women admitted to a tertiary medical center in New York City, an epicenter of the pandemic. Women with a singleton gestation admitted for delivery from March 27 to May 31, 2019, and March 27 to May 31, 2020, were included. Women less than 18 years of age, those with a positive SARS-CoV-2 polymerize chain reaction (PCR) test on admission, fetal anomaly, or multiple gestation were excluded. Adverse pregnancy outcomes were compared between groups. Univariable and multivariable logistic regression analyses were used to assess outcomes. The primary outcome was preterm birth. Results Women who delivered during the 2020 study interval had a significantly higher rate of hypertensive disorders of pregnancy (gestational hypertension [GHTN] or preeclampsia; odds ratio [OR] = 1.40, 95% confidence interval [CI]: 1.05–1.85; p = 0.02), postpartum hemorrhage (PPH; OR = 1.77, 95% CI: 1.14–2.73; p = 0.01), and preterm birth (OR = 1.49, 95% CI: 1.10–2.02; p = 0.01). Gestational age at delivery was significantly lower in the 2020 cohort compared with the 2019 cohort (39.3 versus 39.4 weeks, p = 0.03). After adjusting for confounding variables, multivariate analysis confirmed a persistent increase in hypertensive disorders of pregnancy (OR = 1.56, 95% CI: 1.10–2.20, p = 0.01), PPH (OR = 1.74, 95% CI: 1.06–2.86, p = 0.03), and preterm birth (OR = 1.72, 95% CI: 1.20–2.47, p = 0.003) in patients who delivered in 2020 compared with the same period in 2019. Specifically, medically indicated preterm births increased during the pandemic (OR = 3.17, 95% CI: 1.77–5.67, p < 0.0001). Conclusion Those who delivered during the COVID-19 pandemic study interval were more likely to experience hypertensive disorders of pregnancy, medically indicated preterm birth, and PPH even in the absence of SARS-CoV2 infection. Key Points
37
WHO Declares COVID-19 a Pandemic.
Domenico Cucinotta, Maurizio Vanelli · PubMed · 2020 · 7.8K citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +17
Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia
Huaping Zhu, Lin Wang, Chengzhi Fang et al. · Translational Pediatrics · 2020 · 1.5K citations · Full text
Pathik D. Wadhwa, Curt A. Sandman, Manuel Porto et al. · American Journal of Obstetrics and Gynecology · 1993 · 795 citations · Full text
Rachel L. Copper, Robert L. Goldenberg, Anita Das et al. · American Journal of Obstetrics and Gynecology · 1996 · 693 citations